Annual SGA
$151.39 M
+$22.13 M+17.12%
December 31, 2023
Summary
- As of February 7, 2025, MRVI annual SGA is $151.39 million, with the most recent change of +$22.13 million (+17.12%) on December 31, 2023.
- During the last 3 years, MRVI annual SGA has risen by +$57.15 million (+60.63%).
- MRVI annual SGA is now at all-time high.
Performance
MRVI SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$39.09 M
-$1.47 M-3.62%
September 30, 2024
Summary
- As of February 7, 2025, MRVI quarterly SGA is $39.09 million, with the most recent change of -$1.47 million (-3.62%) on September 30, 2024.
- Over the past year, MRVI quarterly SGA has increased by +$223.00 thousand (+0.57%).
- MRVI quarterly SGA is now -6.09% below its all-time high of $41.62 million, reached on December 31, 2020.
Performance
MRVI Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
$992.51 M
-$224.66 M-18.46%
September 30, 2024
Summary
- As of February 7, 2025, MRVI TTM SGA is $992.51 million, with the most recent change of -$224.66 million (-18.46%) on September 30, 2024.
- Over the past year, MRVI TTM SGA has increased by +$842.39 million (+561.16%).
- MRVI TTM SGA is now -37.94% below its all-time high of $1.60 billion.
Performance
MRVI TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
MRVI Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.1% | +0.6% | +561.2% |
| 3 y3 years | +60.6% | +0.6% | +561.2% |
| 5 y5 years | +267.5% | +0.6% | +561.2% |
MRVI Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +51.3% | -4.4% | +52.8% | -37.9% | +142.5% |
| 5 y | 5-year | at high | +213.1% | -6.1% | +147.6% | -37.9% | +1147.0% |
| alltime | all time | at high | +267.5% | -6.1% | +147.6% | -37.9% | +1147.0% |
Maravai LifeSciences Holdings Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $39.09 M(-3.6%) | $159.01 M(+0.1%) |
| Jun 2024 | - | $40.56 M(-0.8%) | $158.78 M(+3.4%) |
| Mar 2024 | - | $40.88 M(+6.3%) | $153.60 M(+1.5%) |
| Dec 2023 | $151.39 M(+17.1%) | $38.48 M(-1.0%) | $151.39 M(+0.8%) |
| Sep 2023 | - | $38.86 M(+9.9%) | $150.12 M(+5.7%) |
| Jun 2023 | - | $35.38 M(-8.5%) | $142.05 M(+5.4%) |
| Mar 2023 | - | $38.67 M(+3.9%) | $134.73 M(+4.2%) |
| Dec 2022 | $129.26 M | $37.20 M(+20.8%) | $129.26 M(+9.9%) |
| Sep 2022 | - | $30.80 M(+9.7%) | $117.64 M(+3.8%) |
| Jun 2022 | - | $28.06 M(-15.5%) | $113.35 M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $33.20 M(+29.8%) | $109.79 M(+9.7%) |
| Dec 2021 | $100.06 M(+6.2%) | $25.58 M(-3.5%) | $100.06 M(-13.8%) |
| Sep 2021 | - | $26.51 M(+8.2%) | $116.10 M(+5.5%) |
| Jun 2021 | - | $24.50 M(+4.4%) | $110.10 M(+8.4%) |
| Mar 2021 | - | $23.47 M(-43.6%) | $101.59 M(+7.8%) |
| Dec 2020 | $94.25 M(+94.9%) | $41.62 M(+102.9%) | $94.25 M(+37.8%) |
| Sep 2020 | - | $20.51 M(+28.3%) | $68.41 M(+42.8%) |
| Jun 2020 | - | $15.99 M(-0.9%) | $47.90 M(+50.1%) |
| Mar 2020 | - | $16.13 M(+2.2%) | $31.91 M(+102.2%) |
| Dec 2019 | $48.35 M(+17.4%) | $15.78 M | $15.78 M |
| Dec 2018 | $41.19 M | - | - |
FAQ
- What is Maravai LifeSciences Holdings annual SGA?
- What is the all time high annual SGA for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings annual SGA year-on-year change?
- What is Maravai LifeSciences Holdings quarterly SGA?
- What is the all time high quarterly SGA for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings quarterly SGA year-on-year change?
- What is Maravai LifeSciences Holdings TTM SGA?
- What is the all time high TTM SGA for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings TTM SGA year-on-year change?
What is Maravai LifeSciences Holdings annual SGA?
The current annual SGA of MRVI is $151.39 M
What is the all time high annual SGA for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high annual SGA is $151.39 M
What is Maravai LifeSciences Holdings annual SGA year-on-year change?
Over the past year, MRVI annual SGA has changed by +$22.13 M (+17.12%)
What is Maravai LifeSciences Holdings quarterly SGA?
The current quarterly SGA of MRVI is $39.09 M
What is the all time high quarterly SGA for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high quarterly SGA is $41.62 M
What is Maravai LifeSciences Holdings quarterly SGA year-on-year change?
Over the past year, MRVI quarterly SGA has changed by +$223.00 K (+0.57%)
What is Maravai LifeSciences Holdings TTM SGA?
The current TTM SGA of MRVI is $992.51 M
What is the all time high TTM SGA for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high TTM SGA is $1.60 B
What is Maravai LifeSciences Holdings TTM SGA year-on-year change?
Over the past year, MRVI TTM SGA has changed by +$842.39 M (+561.16%)